(1S,2S)-N1,N1,N2-Trimethylcyclohexane-1,2-diamine, 97.0%, 250mg

5-(CHLOROMETHYL)-3-(3-FLUOROPHENYL)-1,2,4-OXADIAZOLE, 95.0%, 10g

2-hydroxy-3,3-dimethylbicyclo[2.2.1]heptane-1-carboxylic acid, 95.0%, 250mg

Lenalidomide, 96.00%, 10g

Triethoxy(p-tolyl)silane>95.0%(GC)5g

4-Bromo-1-fluoro-2-(2-methoxyethoxy)-benzene, 98.0%, 1g

1-Cyanocyclopentane-1-carboxylic acid, 95.0%, 250mg

(S)-2-((S)-2-Amino-3-carboxypropanamido)succinic acid, 95.0%, 1g

(1,1-Dimethylethyl)dimethyl[[(3β,5E,7E)-9,10-secocholesta-5,7,10(19)-trien-3-yl]oxy]silane, 98%, 10g

4-(2-Chloroethyl)morpholine hydrochloride, 95.0%, 500g

2-Chloro-5-hydroxynicotinic acid, 95.0%, 250mg

4,5,6,7-Tetrahydro-2-methyl-2H-pyrazolo[4,3-c]pyridine dihydrochloride, 95.0%, 250mg

2-(2-Aminoethyl)-1,3-dioxolane>98.0%(GC)(T)5g